Skip to main content
Erschienen in: Head and Neck Pathology 4/2022

14.07.2022 | Original Paper

NKX3.1 Expression in Salivary Gland “Intraductal” Papillary Mucinous Neoplasm: A Low-Grade Subtype of Salivary Gland Mucinous Adenocarcinoma

verfasst von: Masato Nakaguro, Peter M. Sadow, Rong Hu, Hikaru Hattori, Kyoko Kuwabara, Toyonori Tsuzuki, Makoto Urano, Toshitaka Nagao, William C. Faquin

Erschienen in: Head and Neck Pathology | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Salivary gland intraductal papillary mucinous neoplasm (SG IPMN) is a recently proposed entity characterized by a papillary-cystic proliferation of mucin-producing cells. Because of overlapping histologic features and a clonal AKT1 p.E17K variant, SG IPMN has been presumed to be a precursor or a low-grade subtype of mucinous adenocarcinoma. NKX3.1 is a tumor suppressor gene located on chromosome 8p and is a known immunohistochemical marker of prostate epithelium and mucinous acinar cells of the intraoral salivary glands.

Methods

We retrieved 12 SG IPMN cases, and performed histologic and genetic analysis. Given the association of SG IPMN with mucinous acinar cells, we also investigated the performance of NKX3.1 as a marker of this tumor entity.

Results

Diffuse and strong NKX3.1 expression was observed in all SG IPMN cases (12/12, 100%) as well as in normal mucinous acinar cells. In contrast, mucoepidermoid carcinoma and pancreatic IPMN cases as well as normal serous acinar cells were negative for NKX3.1. Genetically, 11 of 12 cases (92%) harbored an AKT1 p.E17K variant. A novel PTEN frameshift deletion (p.G36Dfs*18) was detected in the other single case. At least one of the histologic features implying malignant tumors, such as severe cellular atypia, brisk mitotic activity, high Ki-67 proliferating index, lymphovascular invasion, and lymph node metastasis, was detected in 6 SG IPMN cases (50%).

Conclusion

The findings suggest that SG IPMN is a low-grade subtype of mucinous adenocarcinoma which may be derived from mucinous acinar cells of the minor salivary gland.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Rooper LM, Argyris PP, Thompson LDR, Gagan J, Westra WH, Jordan RC, et al. Salivary mucinous adenocarcinoma is a histologically diverse single entity with recurrent AKT1 E17K mutations: clinicopathologic and molecular characterization with proposal for a unified classification. Am J Surg Pathol. 2021;45(10):1337–47.CrossRef Rooper LM, Argyris PP, Thompson LDR, Gagan J, Westra WH, Jordan RC, et al. Salivary mucinous adenocarcinoma is a histologically diverse single entity with recurrent AKT1 E17K mutations: clinicopathologic and molecular characterization with proposal for a unified classification. Am J Surg Pathol. 2021;45(10):1337–47.CrossRef
3.
Zurück zum Zitat Agaimy A, Mueller SK, Bumm K, Iro H, Moskalev EA, Hartmann A, et al. Intraductal papillary mucinous neoplasms of minor salivary glands with AKT1 p.Glu17Lys mutation. Am J Surg Pathol. 2018;42(8):1076–82.CrossRef Agaimy A, Mueller SK, Bumm K, Iro H, Moskalev EA, Hartmann A, et al. Intraductal papillary mucinous neoplasms of minor salivary glands with AKT1 p.Glu17Lys mutation. Am J Surg Pathol. 2018;42(8):1076–82.CrossRef
4.
Zurück zum Zitat Nakaguro M, Urano M, Ogawa I, Hirai H, Yamamoto Y, Yamaguchi H, et al. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm. Histopathology. 2020;76(3):411–22.CrossRef Nakaguro M, Urano M, Ogawa I, Hirai H, Yamamoto Y, Yamaguchi H, et al. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm. Histopathology. 2020;76(3):411–22.CrossRef
5.
Zurück zum Zitat Skálová A, Hyrcza MD, Leivo I. Update from the 5th edition of the World Health Organization classification of head and neck tumors: salivary glands. Head Neck Pathol. 2022;16(1):40–53.CrossRef Skálová A, Hyrcza MD, Leivo I. Update from the 5th edition of the World Health Organization classification of head and neck tumors: salivary glands. Head Neck Pathol. 2022;16(1):40–53.CrossRef
6.
Zurück zum Zitat Bishop JA. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: emerging entities in salivary gland tumor pathology. Head Neck Pathol. 2022;16(1):179–89.CrossRef Bishop JA. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: emerging entities in salivary gland tumor pathology. Head Neck Pathol. 2022;16(1):179–89.CrossRef
7.
Zurück zum Zitat Griffin J, Chen Y, Catto JWF, El-Khamisy S. Gene of the month: NKX3.1. J Clin Pathol. 2022;75(6):361–4.CrossRef Griffin J, Chen Y, Catto JWF, El-Khamisy S. Gene of the month: NKX3.1. J Clin Pathol. 2022;75(6):361–4.CrossRef
8.
Zurück zum Zitat Schneider A, Brand T, Zweigerdt R, Arnold H. Targeted disruption of the Nkx3.1 gene in mice results in morphogenetic defects of minor salivary glands: parallels to glandular duct morphogenesis in prostate. Mech Dev. 2000;95(1–2):163–74.CrossRef Schneider A, Brand T, Zweigerdt R, Arnold H. Targeted disruption of the Nkx3.1 gene in mice results in morphogenetic defects of minor salivary glands: parallels to glandular duct morphogenesis in prostate. Mech Dev. 2000;95(1–2):163–74.CrossRef
9.
Zurück zum Zitat Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010;34(8):1097–105.CrossRef Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010;34(8):1097–105.CrossRef
10.
Zurück zum Zitat Tanaka M, Komuro I, Inagaki H, Jenkins NA, Copeland NG, Izumo S. Nkx3.1, a murine homolog of Ddrosophila bagpipe, regulates epithelial ductal branching and proliferation of the prostate and palatine glands. Dev Dyn. 2000;219(2):248–60.CrossRef Tanaka M, Komuro I, Inagaki H, Jenkins NA, Copeland NG, Izumo S. Nkx3.1, a murine homolog of Ddrosophila bagpipe, regulates epithelial ductal branching and proliferation of the prostate and palatine glands. Dev Dyn. 2000;219(2):248–60.CrossRef
11.
Zurück zum Zitat Yoshida KI, Machado I, Motoi T, Parafioriti A, Lacambra M, Ichikawa H, et al. NKX3-1 is a useful immunohistochemical marker of EWSR1-NFATC2 sarcoma and mesenchymal chondrosarcoma. Am J Surg Pathol. 2020;44(6):719–28.CrossRef Yoshida KI, Machado I, Motoi T, Parafioriti A, Lacambra M, Ichikawa H, et al. NKX3-1 is a useful immunohistochemical marker of EWSR1-NFATC2 sarcoma and mesenchymal chondrosarcoma. Am J Surg Pathol. 2020;44(6):719–28.CrossRef
12.
Zurück zum Zitat Takada N, Nishida H, Oyama Y, Kusaba T, Kadowaki H, Arakane M, et al. Immunohistochemical reactivity of prostate-specific markers for salivary duct carcinoma. Pathobiology. 2020;87(1):30–6.CrossRef Takada N, Nishida H, Oyama Y, Kusaba T, Kadowaki H, Arakane M, et al. Immunohistochemical reactivity of prostate-specific markers for salivary duct carcinoma. Pathobiology. 2020;87(1):30–6.CrossRef
13.
Zurück zum Zitat Yang RK, Zhao P, Lu C, Luo J, Hu R. Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas. Hum Pathol. 2019;84:173–82.CrossRef Yang RK, Zhao P, Lu C, Luo J, Hu R. Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas. Hum Pathol. 2019;84:173–82.CrossRef
14.
Zurück zum Zitat Agaimy A. Papillary neoplasms of the salivary duct system: a review. Surg Pathol Clin. 2021;14(1):53–65.CrossRef Agaimy A. Papillary neoplasms of the salivary duct system: a review. Surg Pathol Clin. 2021;14(1):53–65.CrossRef
15.
Zurück zum Zitat Zheng Z, Liebers M, Zhelyazkova B, Cao Y, Panditi D, Lynch KD, et al. Anchored multiplex PCR for targeted next-generation sequencing. Nat Med. 2014;20(12):1479–84.CrossRef Zheng Z, Liebers M, Zhelyazkova B, Cao Y, Panditi D, Lynch KD, et al. Anchored multiplex PCR for targeted next-generation sequencing. Nat Med. 2014;20(12):1479–84.CrossRef
16.
Zurück zum Zitat Chu YH, Wirth LJ, Farahani AA, Nosé V, Faquin WC, Dias-Santagata D, et al. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization. Mod Pathol. 2020;33(12):2458–72.CrossRef Chu YH, Wirth LJ, Farahani AA, Nosé V, Faquin WC, Dias-Santagata D, et al. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization. Mod Pathol. 2020;33(12):2458–72.CrossRef
17.
Zurück zum Zitat Urano M, Nakaguro M, Yamamoto Y, Hirai H, Tanigawa M, Saigusa N, et al. Diagnostic significance of HRAS mutations in epithelial-myoepithelial carcinomas exhibiting a broad histopathologic spectrum. Am J Surg Pathol. 2019;43(7):984–94.CrossRef Urano M, Nakaguro M, Yamamoto Y, Hirai H, Tanigawa M, Saigusa N, et al. Diagnostic significance of HRAS mutations in epithelial-myoepithelial carcinomas exhibiting a broad histopathologic spectrum. Am J Surg Pathol. 2019;43(7):984–94.CrossRef
18.
Zurück zum Zitat Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, Yamamoto M, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2011;1:161.CrossRef Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, Yamamoto M, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2011;1:161.CrossRef
19.
Zurück zum Zitat Nakaguro M, Tada Y, Faquin WC, Sadow PM, Wirth LJ, Nagao T. Salivary duct carcinoma: updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol. 2020;128(10):693–703.CrossRef Nakaguro M, Tada Y, Faquin WC, Sadow PM, Wirth LJ, Nagao T. Salivary duct carcinoma: updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol. 2020;128(10):693–703.CrossRef
20.
Zurück zum Zitat Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2(7):489–501.CrossRef Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2(7):489–501.CrossRef
21.
Zurück zum Zitat Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 2009;9(8):550–62.CrossRef Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 2009;9(8):550–62.CrossRef
22.
Zurück zum Zitat Yang S, Zeng M, Chen X. Intraductal papillary mucinous neoplasm of the minor salivary gland with associated invasive micropapillary carcinoma. Am J Surg Pathol. 2019;43(10):1439–42.CrossRef Yang S, Zeng M, Chen X. Intraductal papillary mucinous neoplasm of the minor salivary gland with associated invasive micropapillary carcinoma. Am J Surg Pathol. 2019;43(10):1439–42.CrossRef
23.
Zurück zum Zitat Miura A, Mori T, Yoshida A, Watanabe Y, Sunami K, Watanabe S, et al. Primary adenocarcinoma of the trachea revealing a mucinous bronchial gland cell origin. Pathol Res Pract. 2018;214(5):796–9.CrossRef Miura A, Mori T, Yoshida A, Watanabe Y, Sunami K, Watanabe S, et al. Primary adenocarcinoma of the trachea revealing a mucinous bronchial gland cell origin. Pathol Res Pract. 2018;214(5):796–9.CrossRef
Metadaten
Titel
NKX3.1 Expression in Salivary Gland “Intraductal” Papillary Mucinous Neoplasm: A Low-Grade Subtype of Salivary Gland Mucinous Adenocarcinoma
verfasst von
Masato Nakaguro
Peter M. Sadow
Rong Hu
Hikaru Hattori
Kyoko Kuwabara
Toyonori Tsuzuki
Makoto Urano
Toshitaka Nagao
William C. Faquin
Publikationsdatum
14.07.2022
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 4/2022
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-022-01471-4

Weitere Artikel der Ausgabe 4/2022

Head and Neck Pathology 4/2022 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …